James W. Green - Jul 8, 2022 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role: Chief Executive Officer, Director
Signature: /s/ David Sirois, by power of attorney
Stock symbol: HBIO
Transactions as of: Jul 8, 2022
Transactions value $: -$361,807
Form type: 4
Date filed: 7/12/2022, 04:03 PM
Previous filing: Jun 17, 2022
Next filing: Aug 18, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HBIO	Common Stock	Tax liability	-$362K	-92.8K	-4.03%	$3.90	2.21M	Jul 8, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a performance restricted stock unit award previously granted to the Reporting Person that vested in part on July 8, 2022.
F2	Includes (a) 157,037 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, (b) 109,071 remaining restricted stock units that will vest on June 11, 2023, (c) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (d) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (e) 104,590 remaining restricted stock units that will vest on January 1, 2023, (f) 332,039 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (g) 1,267,205 shares of common stock beneficially owned by the Reporting Person.

Content

The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a performance restricted stock unit award previously granted to the Reporting Person that vested in part on July 8, 2022.

Includes (a) 157,037 restricted stock units that will vest in three equal installments on December 29, 2022, 2023 and 2024, (b) 109,071 remaining restricted stock units that will vest on June 11, 2023, (c) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (d) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (e) 104,590 remaining restricted stock units that will vest on January 1, 2023, (f) 332,039 restricted stock units with performance based vesting conditions tied to relative total shareholder return and (g) 1,267,205 shares of common stock beneficially owned by the Reporting Person.